NDC 64842-0727

INQOVI

Cedazuridine And Decitabine

INQOVI is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Taiho Pharmaceutical Co., Ltd.. The primary component is Cedazuridine; Decitabine.

• Product ID: 64842-0727_3ac05368-3848-4904-bab0-0aa2bafbb127
• NDC: 64842-0727
• Product Type: Human Prescription Drug
• Proprietary Name: INQOVI
• Generic Name: Cedazuridine And Decitabine
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2020-07-07
• Marketing Category: NDA / NDA
• Application Number: NDA212576
• Labeler Name: Taiho Pharmaceutical Co., Ltd.
• Substance Name: CEDAZURIDINE; DECITABINE
• Active Ingredient Strength: 100 mg/1; mg/1
• Pharm Classes: Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 64842-0727-9

1 BLISTER PACK in 1 CARTON (64842-0727-9) > 5 TABLET, FILM COATED in 1 BLISTER PACK

• Marketing Start Date: 2020-08-25
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details